Merit Medical Systems, Inc.

Merit Medical Systems, Inc.

MMSI
Merit Medical Systems, Inc.US flagNASDAQ Global Select
67.24
USD
+0.71
- -
4.01BMarket Cap
Merit Medical Systems, Inc.
MMSI
(NASDAQ Global Select)

Recent

price

67.24

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
8.41
9.2
9.35
10.54
11.81
12.31
13.6
14.91
16.89
18.06
17.39
19.14
20.26
21.83
23.3
25.62
26.01
Revenue per Share
0.35
0.59
0.47
0.39
0.53
0.54
0.45
0.56
0.8
0.1
-0.18
0.86
1.31
1.64
2.07
2.17
2.35
Basic EPS, GAAP
0.28
-0.7
1.11
1.21
1.24
1.58
1.21
1.29
1.66
1.41
2.98
2.62
2.01
2.52
3.79
5.03
5.02
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
4.75
9.13
9.08
9.5
10.14
10.71
11.26
13.83
17.88
17.34
17.39
18.66
20.35
21.07
24.03
26.84
27.56
Book Value per Share
3.39
6.12
2.09
2.38
3.26
3.91
2.33
4.32
2.58
2.75
4.1
6.39
8.96
8.58
7.17
9.12
10.31
Tangible Book Value per Share
35
39
42
43
43
44
44
49
52
55
55
56
57
58
58
59
59
Basic Weighted Avg Shares
297
359
394
449
510
542
604
728
883
995
964
1,075
1,151
1,257
1,357
1,516
1,542
Sales/Revenue/Turnover
8.61
10.86
8.14
7.09
7.98
7.12
5.86
6.28
6.71
3.97
4.76
7.29
8.78
10.14
11.51
12.25
12.16
Operating Margin (%)
15
19
23
33
36
37
44
54
70
104
107
96
92
101
115
135
136
Depreciation Expense
12
23
20
17
23
24
20
28
42
5
-10
48
75
94
120
128
139
Net Income, GAAP
25.78
29.9
28.63
16.48
27.23
23.71
20.74
23.29
15.15
- -
- -
10.13
9.82
15.77
19.76
24.83
25.3
Effective Tax Rate (%)
4.2
6.41
5
3.69
4.51
4.39
3.33
3.78
4.76
0.55
-1.02
4.51
6.47
7.51
8.87
8.48
9.03
Profit Margin (%)
72
90
89
100
117
116
155
201
254
273
245
246
308
905
707
800
885
Working Capital
83
31
228
239
214
198
314
259
373
505
415
296
246
879
784
811
810
LT Debt
236
357
382
406
435
466
498
676
933
950
959
1,040
1,144
1,202
1,379
1,584
1,627
Total Equity
6.96
7.71
4.52
4.16
4.48
4.39
3.74
3.94
4.4
- -
- -
5.14
6.6
6.13
5.89
6.11
5.97
Return on Invested Capital (%)
6.25
7.39
4
3.66
4.47
4.26
3.6
3.76
4.45
- -
- -
3.85
5.76
6.09
6.77
6.45
6.74
Return on Capital (%)
7.72
8.79
5.33
4.21
5.45
5.24
4.14
4.69
5.22
0.58
-1.03
4.82
6.76
7.97
9.22
8.6
9.05
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
11
11
11
LT Borrowings
733
734
735
LT Finance Leases
78
77
75
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
59
59
60
Market Capitalization
4,907
5,214
4,088

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
986
1,040
1,102
Cash, Cash Equivalents & STI
392
446
488
Accounts Receivable, Net
210
204
206
Inventories
327
334
352
Total Current Liabilities
230
240
217
Payables & Accruals
220
229
206
ST Debt
11
11
11
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.65%
10.64%
14.86%
Free Cash Flow
21.5%
16.1%
34.68%
Net Income, GAAP
-77.12%
-95.51%
6.76%
Sales/Revenue/Turnover
11.03%
9.49%
11.75%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
324
338
340
355
1,357
2025
355
382
384
394
1,516
2026
382
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.49
0.61
0.49
0.48
2.07
2025
0.51
0.55
0.47
0.64
2.17
2026
0.69
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Merit Medical Systems, Inc. is a leading worldwide designer, developer, manufacturer, and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Founded in 1987 and headquartered in South Jordan, Utah, the company operates in two primary segments, Cardiovascular and Endoscopy, offering a broad portfolio of products including micropuncture kits, angiographic needles, sheaths, guidewires, safety devices, inflation devices for angioplasty and stent placement, diagnostic and therapeutic catheters, thrombolytic catheters, fluid dispensing systems, angiography accessories, hemostatic solutions, and procedural kits for peripheral intervention, spine, and oncology applications; it serves hospitals, physicians, and clinicians globally with approximately 7,000 employees and manufacturing facilities worldwide. In May 2025, Merit acquired Biolife Delaware, L.L.C. for approximately $120 million in cash and assumed liabilities, adding the patented StatSeal and WoundSeal hemostatic products that address a $350 million global market opportunity and are projected to contribute $18 million in annual revenue starting in fiscal 2026; earlier transactions include the November 2024 acquisition of assets from Cook Medical Holdings LLC and the July 2024 acquisition of EndoGastric Solutions, Inc., alongside a signed asset purchase agreement in October 2025 for the C2 CryoBalloon from PENTAX Medical to expand its gastroenterology portfolio.

Company News

MCPAPIChat
  • Is the Options Market Predicting a Spike in Merit Medical Systems Stock?

  • Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now

  • Merit Medical Systems, Inc. (MMSI) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

  • Here's Why Merit Medical (MMSI) is a Strong Value Stock

  • Merit Medical Systems Inc (MMSI) Shares Fall 3.1% -- What GF Score of 79 Tells Investors

  • Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term

  • Merit Medical Shareholders Elect Scott R. Ward to Board of Directors

  • A Merit Medical Systems Director Sold 5,000 Company Shares. What Does That Mean for Investors?

  • Merit Medical Systems, Inc. (MMSI) Presents at Bank of America Global Healthcare Conference 2026 Transcript

  • Merit Medical to Participate in the Bank of America Healthcare Conference

  • Why Merit Medical (MMSI) is a Top Value Stock for the Long-Term

  • Merit Medical Systems: Creating More Growth Engines (Rating Upgrade)

  • Merit Medical Q1 Earnings & Revenues Beat Estimates, Sales View Up

  • Merit Medical Systems, Inc. (MMSI) Q1 2026 Earnings Call Transcript

  • Merit Medical (MMSI) Q1 Earnings and Revenues Beat Estimates

  • Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance

  • Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now

  • A Look at Merit Medical Systems Inc (MMSI) After 3.4% Gain -- GF Value $96.06 vs Price $70.57

  • Here's Why Merit Medical (MMSI) is a Strong Growth Stock

  • Merit Medical (MMSI) is a Top-Ranked Value Stock: Should You Buy?